API Supplies Products
| Product | Therapeutic category | DMF |
|---|---|---|
| Aminocaprioc acid | Clotting promoter | DMF Ready |
| Chlorzoxazone | Muscle relaxant | USDMF |
| Canagliflozin (Amorphous) | Antidiabetic | USDMF |
| Canagliflozin Hemihydrate | Antidiabetic | USDMF |
| Chlorpromazine Hydrochloride | Antipsychotic | USDMF |
| Dapsone | Anti-Bacterial / Anti Acne | USDMF |
| Doxercalciferol | Hyperparathyroidism | USDMF |
| Droxidopa | Neurogenic orthostatic hypotension | USDMF |
| Eslicarbazepine acetate | Anticonvulsant | USDMF |
| Emtricitabine | Antiretroviral | USDMF |
| Efavirenz | Antiretroviral | USDMF |
| Gabapentin Enacarbil | Analgesic | USDMF |
| Mycophenolate Mofetil | Immunosuppressive agent | DMF |
| Nimodipine | Anti-hypertensive | USDMF |
| Nitazoxanide | Ant parasitic / Antiviral drug | USDMF |
| Oseltamivir Phosphate | Antiviral (Influenza) drug | USDMF |
| Oxcarbazepine | Anticonvulsant | USDMF |
| Pimavanserin tartrate | Typical antipsychotic | USDMF |
| Pregabalin | Muscle Relaxant | USDMF/ CEP/ KDMF |
| Ranolazine | Anti Anginal | USDMF/ ASMF |
| Sitagliptin Hydrochloride | Antidiabetic | USDMF / ASMF |
| Sitagliptin Phosphate (mono) | Antidiabetic | USDMF / CEP |
| Tenofovir Disproxil Fumarate | Anti HIV / AIDS | USDMF |
| Trientine Hydrochloride | Wilson's disease | USDMF |
| Tolvaptan | Hyponatremia | USDMF |
| Terazosin | Antihypertensive | USDMF |
| Valacyclovir HCl monohydrate | Antiviral | Filed (US) |
New Products (For Regulatory market)
| Product | Therapeutic category | DMF |
|---|---|---|
| Carboprost Tromethamine | Prostaglandin | DMF Q2 |
| Eltrombopag Olamine | Thrombopoietin-receptor agonist | DMF Q2 |
| Levocetirizine | Antihistamine | USDMF Q2 |
| Nitrofurantoin Macrocrystals | Antibiotic for UT Infections | USDMF Q2 |
| Prazosin Hydrochloride | Anti-hypertensive | USDMF Q2 |
| Ropinirole Hydrochloride | Anti-Parkinson’s | USDMF Q2 |
| Fluvoxamine maleate | SSRI | Validation to be planned |
| Suggamdex Sodium | Neuromuscular | USDMF Q2 |
| Spironolactone | Anti-mineralocorticoid | Under Development |
| Verapamil HCL | Calcium-channel blocker | Under Development |
| Ziprasidone Mesylate Trihydrate | Anti-Schizophrenia | USDMF Q2 |
Oncology Products (For Regulatory market)
| Product | Therapeutic category | DMF |
|---|---|---|
| Bicalutamide | Anti-Cancer | To be filed |
| Erlotinib (Form A) | Anti-Cancer | Under Development |
| Bendamustine HCl | Anti-Cancer | Under Development |
| Cyclophosphamide ( Monohydrate) | Anti-Cancer | Under Development |
| Imatinib Mesylate (Beta Form) | Anti-Cancer | Under Development |
New Products (For ROW)
| Product | Therapeutic category | DMF |
|---|---|---|
| Bimatoprost | IH | Available |
| Brivaracetam | ICH | Available |
| Cetirizine | USP | Available |
| Chloprostenol Sodium | USP / IH | Available |
| Dinoprostone | USP / IH | Available |
| Doxazosin Mesylate | IH | Available |
| Latanoprost | USP / IH | Available |
| Misoprostol | USP | Available |
| Oclacitinib Maleate | IH | Available (Veterinary API) |
| Silodosin | IH | Available |
| Trazodone | USP | Available |
| Travoprost | USP | Available |
| Tafluprost | IH | Available |
| Vildagliptin | IH | Available |
| Ziprasidone DiHCL | USP | Available |